For those finding the new research paper from Saudi a bit tough going, here are some highlights
Abstract
Note references 9 &10 from the above yellow highlight referencing the drugs they are discussing:
Well, there really isn't that much more to say apart from jumping into the finer details of the paper. Their conclusion about Biotron's compounds says it all.
However, they didn't refer to BIT036 - Cinnamoylguaginine - that comes up in Biotron's recent patent. Maybe the good Saudi's missed that one. There is some chance that they havn't seen the Patents. But I have forwarded it to them.
You can recall something about it here: https://hotcopper.com.au/posts/43357282/single
COVID-19 as good as cured, page-35
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.003(5.45%) |
Mkt cap ! $46.91M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.6¢ | 5.2¢ | $63.28K | 1.198M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12058 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 33995 | 1 |
View Market Depth
| Last trade - 15.51pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
-0.003 ( 5.45 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.5¢ | 5.2¢ | 64903 | ||
| Last updated 15.35pm 07/06/2024 ? | |||||
| BIT (ASX) Chart |